Treatment of medullary thyroid carcinoma with apatinib: A case report and literature review.

ABSTRACT:

Rationale

Medullary thyroid carcinoma (MTC) is a rare type thyroid carcinoma originating from the thyroid parafollicular cells (C cells). Chemotherapy has a limited efficacy for treating persistent or recurrent MTC.

Patient concerns

A 46-year-old woman who underwent thyroidectomy for MTC in December 2007. She began experience recurring diarrhea in January 2015 and started to cough and feel shortness of breath in March 2016.

Diagnoses

A chestcomputed tomography (CT) scan showed metastases in the bilateral lungs, pulmonary hilum, and mediastinal lymph nodes. Percutaneous biopsy of the pulmonary occupying lesions performed on March 21, 2016 indicated medullary carcinoma metastases at the right pulmonary hilum.

Interventions

This patient was treated with oral apati

SUBMITTER: Cai S 

PROVIDER: S-EPMC5815675 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature